argenx SE reported $473.53M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AstraZeneca USD 6.93B 362M Jun/2026
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Qiagen NV USD 309.61M 7.72M Mar/2026
UCB EUR 1.31B 173M Dec/2024